ArticleInternational journal of molecular sciences2022

Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer.

Jia Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.